Sei Investments CO Ascendis Pharma A/S Transaction History

Sei Investments CO

$74.7 Billion
Q3 2024

A detailed history of Sei Investments CO transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Sei Investments CO holds 273,747 shares of ASND stock, worth $34 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

273,747

Previous 264,571 3.47%

Holding current value

$34 Million

Previous $36.1 Million 13.3%

% of portfolio

0.05%

Previous 0.05%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$113.0 - $153.43 $1.04 Million - $1.41 Million	9,176 Added 3.47%	273,747 $40.9 Million
Q2 2024 Aug 13, 2024	SELL	$121.07 - $153.67 $9.88 Million - $12.5 Million	-81,615 Reduced 23.58%	264,571 $36.1 Million
Q1 2024 May 07, 2024	SELL	$123.45 - $159.4 $1.93 Million - $2.49 Million	-15,644 Reduced 4.32%	346,186 $52.3 Million
Q4 2023 Feb 14, 2024	SELL	$86.1 - $127.36 $2.98 Million - $4.41 Million	-34,610 Reduced 8.73%	361,830 $45.6 Million
Q3 2023 Nov 14, 2023	SELL	$86.5 - $103.97 $1.21 Million - $1.45 Million	-13,944 Reduced 3.4%	396,440 $37.1 Million
Q2 2023 Aug 11, 2023	SELL	$69.96 - $97.84 $4.59 Million - $6.42 Million	-65,637 Reduced 13.79%	410,384 $36.6 Million
Q1 2023 May 12, 2023	BUY	$104.9 - $126.78 $4.07 Million - $4.92 Million	38,770 Added 8.87%	476,021 $51 Million
Q4 2022 Feb 10, 2023	SELL	$99.42 - $131.97 $3.61 Million - $4.79 Million	-36,268 Reduced 7.66%	437,251 $53.4 Million
Q3 2022 Nov 14, 2022	BUY	$84.03 - $110.23 $1.82 Million - $2.39 Million	21,718 Added 4.81%	473,519 $48.9 Million
Q2 2022 Aug 15, 2022	BUY	$78.08 - $117.61 $565,455 - $851,731	7,242 Added 1.63%	451,801 $42 Million
Q1 2022 May 13, 2022	BUY	$102.18 - $135.75 $2.23 Million - $2.97 Million	21,868 Added 5.17%	444,559 $52.2 Million
Q4 2021 Feb 14, 2022	BUY	$127.1 - $169.66 $4.25 Million - $5.68 Million	33,468 Added 8.6%	422,691 $56.9 Million
Q3 2021 Nov 12, 2021	BUY	$112.67 - $176.92 $10.2 Million - $16.1 Million	90,902 Added 30.47%	389,223 $62 Million
Q2 2021 Aug 06, 2021	BUY	$121.62 - $145.29 $4.37 Million - $5.22 Million	35,929 Added 13.69%	298,321 $39.2 Million
Q1 2021 May 12, 2021	BUY	$124.92 - $173.33 $2.41 Million - $3.34 Million	19,290 Added 7.93%	262,392 $33.8 Million
Q4 2020 Feb 08, 2021	BUY	$151.2 - $182.76 $1.26 Million - $1.52 Million	8,328 Added 3.55%	243,102 $40.6 Million
Q3 2020 Nov 06, 2020	BUY	$134.29 - $154.32 $11.3 Million - $13 Million	84,122 Added 55.84%	234,774 $36.2 Million
Q2 2020 Aug 17, 2020	BUY	$110.87 - $156.01 $9.4 Million - $13.2 Million	84,744 Added 128.58%	150,652 $22.3 Million
Q2 2020 Aug 11, 2020	SELL	$110.87 - $156.01 $2.25 Million - $3.16 Million	-20,278 Reduced 23.53%	65,908 $9.17 Million
Q1 2020 May 14, 2020	BUY	$97.01 - $145.11 $1.97 Million - $2.94 Million	20,278 Added 30.77%	86,186 $9.71 Million
Q4 2019 Feb 06, 2020	BUY	$91.45 - $139.12 $82,213 - $125,068	899 Added 1.38%	65,908 $9.17 Million
Q3 2019 Nov 12, 2019	BUY	$95.8 - $118.9 $2.01 Million - $2.49 Million	20,938 Added 47.51%	65,009 $6.26 Million
Q2 2019 Aug 14, 2019	BUY	$107.11 - $132.09 $2.03 Million - $2.51 Million	18,971 Added 75.58%	44,071 $5.08 Million
Q1 2019 May 15, 2019	BUY	$62.15 - $129.99 $1.56 Million - $3.26 Million	25,100 New	25,100 $2.95 Million

Others Institutions Holding ASND

# of Institutions

236

Shares Held

58.2M

Call Options Held

238K

Put Options Held

299K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $6.94B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Ascendis Pharma A/S Transaction History